BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10780879)

  • 41. Molecular profiling in the diagnosis and treatment of high grade sarcomas.
    Antonescu CR
    Ultrastruct Pathol; 2008; 32(2):37-42. PubMed ID: 18446666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
    Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
    J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sarcoma related genes in bone soft tissues].
    Hatanaka M
    Nihon Seikeigeka Gakkai Zasshi; 1993 Jan; 67(1):118-25. PubMed ID: 8454921
    [No Abstract]   [Full Text] [Related]  

  • 44. Soft tissue sarcoma as a model disease to examine cancer immunotherapy.
    Maki RG
    Curr Opin Oncol; 2001 Jul; 13(4):270-4. PubMed ID: 11429485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
    Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
    PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coexpression of survivin and TERT in soft-tissue sarcoma.
    Daidone MG; Porta CD; Pilotti S; Zaffaroni N
    Lancet; 2002 Sep; 360(9336):877. PubMed ID: 12243951
    [No Abstract]   [Full Text] [Related]  

  • 47. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.
    Meye A; Würl P; Hinze R; Berger D; Bache M; Schmidt H; Rath FW; Taubert H
    J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome prediction in patients with localized soft tissue sarcoma: which tool is the best?
    Kasper B; Wardelmann E
    Ann Oncol; 2018 Feb; 29(2):297-298. PubMed ID: 29145565
    [No Abstract]   [Full Text] [Related]  

  • 49. [Soft tissue sarcomas: update on molecular data].
    Bui Nguyen Binh M; Collin F; Coindre JM
    Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retroperitoneal sarcoma.
    Leffall LD
    Ann Surg; 1991 Jul; 214(1):1. PubMed ID: 2064464
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular biological studies on soft tissue sarcomas.
    Cooper CS; Clark J
    Cancer Treat Res; 1993; 67():37-55. PubMed ID: 8102874
    [No Abstract]   [Full Text] [Related]  

  • 52. Bone versus soft-tissue sarcomas in the elderly.
    Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thoracotomy in the management of metastatic soft-tissue sarcomas in adults.
    Rosen G; Holmes EC; Forscher CA; Lowenbraun S; Eilber FR; Eckardt JJ
    Chest Surg Clin N Am; 1994 Feb; 4(1):67-74. PubMed ID: 8055285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas].
    Niu XH; Xu HR
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2399-2404. PubMed ID: 36000368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment.
    Hogendoorn PC; Collin F; Daugaard S; Dei Tos AP; Fisher C; Schneider U; Sciot R;
    Eur J Cancer; 2004 Jul; 40(11):1644-54. PubMed ID: 15251152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
    Marino-Enriquez A
    Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The molecular genetics of soft tissue sarcomas.
    Knight JC
    Eur J Cancer; 1990 Apr; 26(4):511-3. PubMed ID: 2141519
    [No Abstract]   [Full Text] [Related]  

  • 59. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ; Cohen JA; Geradts J
    Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic adjuvant chemotherapy for soft tissue sarcomas.
    Zalupski MM; Baker LH
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):787-800. PubMed ID: 7490241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.